[Federal Register Volume 61, Number 55 (Wednesday, March 20, 1996)]
[Notices]
[Page 11432]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-6692]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 24, 1995, and published in the Federal
Register on November 8, 1995, (60 FR 56354), Hoffmann-LaRoche, Inc.,
340 Kingsland Street, Nutley, New Jersey 07110, made application to the
Drug Enforcement Administration (DEA) to be registered as a bulk
manufacturer of levorphanol (9220), a basic class of controlled
substance listed in Schedule II.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code, Section 823(a) and
determined that the registration of Hoffman-LaRoche, Inc. to
manufacture levorphanol is consistent with the public interest and with
United States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. Therefore, pursuant
to Section 303 of the Comprehensive Drug Abuse Prevention and Control
Act of 1970 and Title 21, Code of Federal Regulations, Section
1301.54(e), the Deputy Assistance Administrator, Office of Diversion
Control, hereby orders that the application submitted by the above firm
for registration as a bulk manufacturer of the basic class of
controlled substance listed above is granted.
Dated: March 11, 1996.
Gene R. Haislip,
Deputy Assistance Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 96-6692 Filed 3-19-96;8:45 am]
BILLING CODE 4410-09-M
